Report cover image

Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Publisher IMARC Services Pvt. Ltd.
Published May 29, 2023
Length 148 Pages
SKU # IMRC17986533

Description

Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global empty capsules market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.

Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient’s body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.

Empty Capsules Market Trends:



The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth. The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global empty capsules market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, raw material, functionality, therapeutic application and end user.

Breakup by Type:

Gelatin Capsule

Non-gelatin Capsule

Breakup by Raw Material:

Pig Meat

Bovine Meat

Bone

Hydroxypropyl Methylcellulose (HPMC)

Others

Breakup by Functionality:

Immediate-release Capsules

Sustained-release Capsules

Delayed-release Capsules

Breakup by Therapeutic Application:

Antibiotic and Antibacterial Drugs

Vitamins and Dietary Supplements

Antacid and Antiflatulent Preparations

Cardiovascular Therapy Drugs

Others

Breakup by End User:

Pharmaceutical Industry

Nutraceutical Industry

Cosmetics Industry

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.

Key Questions Answered in This Report

1. What was the size of the global empty capsules market in 2022?

2. What is the expected growth rate of the global empty capsules market during 2023-2028?

3. What are the key factors driving the global empty capsules market?

4. What has been the impact of COVID-19 on the global empty capsules market?

5. What is the breakup of the global empty capsules market based on the type?

6. What is the breakup of the global empty capsules market based on the raw material?

7. What is the breakup of the global empty capsules market based on the functionality?

8. What is the breakup of the global empty capsules market based on the end user?

9. What are the key regions in the global empty capsules market?

10. Who are the key players/companies in the global empty capsules market?

Table of Contents

148 Pages
1 Preface
2 Scope and Methodology
  2.1 Objectives of the Study
  2.2 Stakeholders
  2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
  2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
  2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
  4.1 Overview
  4.2 Key Industry Trends
5 Global Empty Capsules Market
  5.1 Market Overview
  5.2 Market Performance
  5.3 Impact of COVID-19
  5.4 Market Forecast
6 Market Breakup by Type
  6.1 Gelatin Capsule
6.1.1 Market Trends
6.1.2 Market Forecast
  6.2 Non-gelatin Capsule
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Raw Material
  7.1 Pig Meat
7.1.1 Market Trends
7.1.2 Market Forecast
  7.2 Bovine Meat
7.2.1 Market Trends
7.2.2 Market Forecast
  7.3 Bone
7.3.1 Market Trends
7.3.2 Market Forecast
  7.4 Hydroxypropyl Methylcellulose (HPMC)
7.4.1 Market Trends
7.4.2 Market Forecast
  7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Functionality
  8.1 Immediate-release Capsules
8.1.1 Market Trends
8.1.2 Market Forecast
  8.2 Sustained-release Capsules
8.2.1 Market Trends
8.2.2 Market Forecast
  8.3 Delayed-release Capsules
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Therapeutic Application
  9.1 Antibiotic and Antibacterial Drugs
9.1.1 Market Trends
9.1.2 Market Forecast
  9.2 Vitamins and Dietary Supplements
9.2.1 Market Trends
9.2.2 Market Forecast
  9.3 Antacid and Antiflatulent Preparations
9.3.1 Market Trends
9.3.2 Market Forecast
  9.4 Cardiovascular Therapy Drugs
9.4.1 Market Trends
9.4.2 Market Forecast
  9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10  Market Breakup by End User
  10.1 Pharmaceutical Industry
10.1.1 Market Trends
10.1.2 Market Forecast
  10.2 Nutraceutical Industry
10.2.1 Market Trends
10.2.2 Market Forecast
  10.3 Cosmetics Industry
10.3.1 Market Trends
10.3.2 Market Forecast
  10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11  Market Breakup by Region
  11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
  11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
  11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
  11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
  11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12  SWOT Analysis
  12.1 Overview
  12.2 Strengths
  12.3 Weaknesses
  12.4 Opportunities
  12.5 Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis
  14.1 Overview
  14.2 Bargaining Power of Buyers
  14.3 Bargaining Power of Suppliers
  14.4 Degree of Competition
  14.5 Threat of New Entrants
  14.6 Threat of Substitutes
15  Price Analysis
16  Competitive Landscape
  16.1 Market Structure
  16.2 Key Players
  16.3 Profiles of Key Players
16.3.1 ACG Associated Capsules Pvt. Ltd.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Bright Pharma Caps Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 CapsCanada Corporation
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 HealthCaps India Limited
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Lonza Group AG
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Medicaps Limited
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Nectar Lifesciences Limited
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Roxlor LLC
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Shanxi Guangsheng Medicinal Capsules Co. Ltd
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Snail Pharma Industry Co. Ltd
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Suheung Co. Ltd
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Sunil Healthcare Limited
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us